Singapore markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.4500+0.0500 (+1.14%)
At close: 04:00PM EDT
4.5400 +0.09 (+2.02%)
After hours: 06:51PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-76,659
-54,188
-39,696
-84,936
-84,234
Depreciation & amortisation
3,034
3,198
4,577
4,464
5,601
Stock-based compensation
5,544
4,768
3,051
8,916
8,187
Change in working capital
-2,592
-1,788
-5,892
-18,263
1,634
Accounts receivable
-
0
3,000
-3,000
0
Accounts payable
727
2,041
-9,108
-15,587
-2,178
Other working capital
-40,641
-37,340
-43,613
-69,816
-36,355
Other non-cash items
627
324
356
-6,554
877
Net cash provided by operating activities
-39,803
-37,009
-43,483
-65,665
-35,019
Cash flows from investing activities
Investments in property, plant and equipment
-838
-331
-130
-4,151
-1,336
Purchases of investments
-73,015
-51,636
-78,212
-20,163
-170,472
Sales/maturities of investments
63,829
51,971
52,644
90,376
88,094
Net cash used for investing activities
-9,820
208
-23,964
66,062
-83,714
Cash flows from financing activities
Common stock issued
43,806
37,389
46,960
24,030
1
Common stock repurchased
-
0
-26,250
0
-
Other financing activities
-1,123
-150
-
-1,454
-
Net cash used provided by (used for) financing activities
62,501
37,057
43,173
24,861
1,936
Net change in cash
12,878
256
-24,274
25,258
-116,797
Cash at beginning of period
5,018
14,555
38,829
13,571
130,368
Cash at end of period
17,896
14,811
14,555
38,829
13,571
Free cash flow
Operating cash flow
-39,803
-37,009
-43,483
-65,665
-35,019
Capital expenditure
-838
-331
-130
-4,151
-1,336
Free cash flow
-40,641
-37,340
-43,613
-69,816
-36,355